CDK4 and small cell lung carcinoma: In this regard, it is unknown whether strategies such as inhibition of CDK4/6 kinases to protect immune cells from chemotherapy in SCLC patients (He et al, 2017; Lai et al, 2020) will have effect on metastasis.